Exelixis Inc

US30161Q1040

Exelixis Inc
Sector Healthcare
Currency

RUB

Country

Соединенные Штаты Америки

Get Prediction

Get AI stock predictions on your device

About This Company

Exelixis, Inc. is a biotechnology company specializing in the development of promising small-molecule drugs for the treatment of cancer and other serious diseases, including kidney disease, thyroid cancer, and advanced melanoma. In addition, the company forms strategic partnerships with other pharmaceutical and biotechnology companies.

Get AI Stock Predictions Now

Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS

Download on the App Store Get it on Google Play Get it from Microsoft Store
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.